Skip to main content

Table 2 The prevalence of DPYD gene polymorphisms (n = 73)

From: Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients

Polymorphism

Heterozygous

Homozygote

Absence of polymorphism

Total

IVS 14 + 1 G > A

4 (5.5%)

0

69 (94.5%)

73 (100%)

2846 A > T

0

0

73 (100%)

73 (100%)

2194 G > A

0

0

73 (100%)

73 (100%)